Bioimmunate is a medical device company that offers a precision blood filtering medical technology for select autoimmune diseases. The companys platform technology is initially focused on the treatment of patients with multiple sclerosis (MS). Brain damage from MS is caused by specific MS-related cells that migrate from the blood to the brain. Bioimmunate has developed unique biological filters anchored inside special particles that are able to recognize, capture, and remove these harmful cells from the patients blood before they reach the central nervous system. Bioimmunate is dedicated to improving the quality of life of patients with autoimmune diseases, seeking to provide safer, more cost-effective therapies without side effects. The companys main R&D lab is located at the BioGiv Center at the Hebrew University in Jerusalem.